Hormone Replacement Therapy Formulations and Risk of Epithelial Ovarian Carcinoma

Author： Sit A.S.Y.   Modugno F.   Weissfeld J.L.   Berga S.L.   Ness R.B.  

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.86, Iss.2, 2002-08, pp. : 118-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen Replacement Therapy and Risk of Epithelial Ovarian Cancer

By Risch H.A.  

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 254-257

Academic Press

Access to resources Recommend Favorite

Hormone Replacement Therapy and the Risk of Ovarian Cancer

By Risch H.A.  

Gynecologic Oncology, Vol. 86, Iss. 2, 2002-08 ,pp. : 115-117

Academic Press

Access to resources Recommend Favorite

Endometrial Carcinoma in 45,X Turner's Syndrome without Hormone Replacement Therapy

By Matsui H.   Ishii J.   Onodera T.   Takano H.   Seki K.   Sekiya S.  

Gynecologic Oncology, Vol. 65, Iss. 3, 1997-06 ,pp. : 548-552

Elsevier

Access to resources Recommend Favorite

Aflibercept in epithelial ovarian carcinoma

By Moroney John W   Sood Anil K   Coleman Robert L  

Future Oncology, Vol. 5, Iss. 5, 2009-06 ,pp. : 591-600

Future Medicine

Access to resources Recommend Favorite

Hormone replacement therapy is not associated with an increased risk of leukemia (United States)

By Ross Julie  

Cancer Causes and Control, Vol. 16, Iss. 5, 2005-06 ,pp. : 483-488

Springer Publishing Company

Access to resources Recommend Favorite